Featured2 years ago
Amgen (NASDAQ: AMGN) and TScan Therapeutics, Inc. (NASDAQ: TCRX) Secure Partnership
TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million. Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and...